Skip to content
Screener

Net Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$34.1M-34,000%
NeoGenomics logo
NeoGenomicsNEO
$2.24M+105%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$7.27M+36.6%
IQVIA logo
IQVIAIQV
$258M-3.0%
Guardant Health logo
Guardant HealthGH
-$112.08M-17.8%
Natera, Inc. logo
Natera, Inc.NTRA
-$66.97M+33.7%

Other financials

Income statement

See full
Revenue$382.5M+21.6%
Operating income-$75.9M-22.9%
Net income$5.6M+113%
EPS (diluted)$0.03+112%

Balance sheet

See full
Cash & equivalents$599.6M+219%
Total debt$83.5M+51.1%
Total equity$444.9M+43.7%
Total assets$2.4B+45.6%

Cash flow

See full
Operating cash flow-$7.5M
CapEx-$22.5M-400%
Free cash flow-$30.1M

Valuation

See full
Market cap$8.43B-12.3%
Enterprise value$7.91B-16.6%
P/S5.9×-4.2×

Profitability

See full
Operating margin-19.8%-3.3pp
Net margin-17.8%-2.4pp
FCF margin-19.5%

Returns & leverage

See full
Return on equity-67.4%-16.0pp
Debt / equity0.2×0.0×
Current ratio3.3×+1.8×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Tempus AI, Inc.’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:01 PM EDT
Accession
0001193125-26-326083

FAQ

What is Tempus AI, Inc.'s net income?
Tempus AI, Inc. (TEM) reported net income of $5.64M in Q2 2026.
How has Tempus AI, Inc.'s net income changed year-over-year?
Tempus AI, Inc.'s net income increased by 113.2% year-over-year, from -$42.84M to $5.64M.
What is the long-term trend for Tempus AI, Inc.'s net income?
Over 3 years (2022 to 2025), Tempus AI, Inc.'s net income has grown at a -5.4% compound annual growth rate (CAGR), from -$289.81M to -$245.03M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.

Ask your AI about Tempus AI, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude